In these APL samples collected at the time of complete remission, methylation levels were similar to that of cord blood CD34+ cells and BM-MNC samples collected from healthy donors (2 CD34+ and 5 BM-MNC samples), as well as to that of AML samples at diagnosis (Figure 2A). The gene discussed is CD34; the disease is acute promyelocytic leukemia.